4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0000899243-20-021969
Options or other derivatives
- Chief Operating Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bisker-Leib Vered Chief Operating Officer | 2020-08-06 | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | D | ||
Loading xslF345X03/doc4.xml…